OncoImmunology
Volume 9, 2020 - Issue 1
Open access
3,376
Views
18
CrossRef citations to date
0
Altmetric
Research Article
The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines
Stine Emilie Weis-Bankea National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Copenhagen, DenmarkView further author information
, Mie Linder Hübbea National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Copenhagen, DenmarkView further author information
, Morten Orebo Holmströma National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Copenhagen, Denmark
https://orcid.org/0000-0002-3764-8578View further author information
Mia Aaboe Jørgensena National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Copenhagen, DenmarkView further author information
, Simone Kloch Bendtsena National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Copenhagen, DenmarkView further author information
, Evelina Martinenaitea National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Copenhagen, Denmark;b IO Biotech ApS, Copenhagen, DenmarkView further author information
, Marco Carrettaa National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Copenhagen, DenmarkView further author information
, Inge Marie Svanea National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Copenhagen, Denmark
https://orcid.org/0000-0002-9451-6037View further author information
Niels Ødumc Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, DenmarkView further author information
, Ayako Wakatsuki Pedersenb IO Biotech ApS, Copenhagen, DenmarkView further author information
, Özcan Meta National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Copenhagen, Denmark
https://orcid.org/0000-0002-3256-7592View further author information
Daniel Hargbøl Madsena National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Copenhagen, DenmarkView further author information
& Mads Hald Andersena National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev, Copenhagen, Denmark;b IO Biotech ApS, Copenhagen, Denmark;c Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, DenmarkCorrespondence[email protected]
https://orcid.org/0000-0002-2914-9605View further author information
Article: 1771142
|
Received 30 Mar 2020, Accepted 15 May 2020, Published online: 01 Jun 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.